BAM
LABU icon

Belpointe Asset Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Belpointe Asset Management’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-150
Closed -$14.7K – 2101
2023
Q1 		$14.7K Buy
+150
New +$20.3K ﹤0.01% 2491

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
G
Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return

Belpointe Asset Management's LABU Position: Q2 2023 in Review

Belpointe Asset Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2023, closing a stake of 150 shares — an estimated $14.7K sold.

Belpointe Asset Management first reported a position in LABU in Q1 2023 and held it in 1 quarter. The position peaked at $14.7K in Q1 2023. 51 funds tracked by Wall St. Rank hold LABU as of Q2 2023.

  • Belpointe Asset Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 150 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2023, an estimated $14.7K.
  • Belpointe Asset Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2023 and held it in 1 quarter.
  • Belpointe Asset Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $14.7K in Q1 2023.
  • 51 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.